サンプル依頼リスト カート
  • English
  • Korean
表紙：筋骨格系障害治療薬の世界市場（2022年）
市場調査レポート
商品コード
1063052

筋骨格系障害治療薬の世界市場（2022年）

Musculoskeletal Disorders Drugs Global Market Report 2022
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 300 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.42円
筋骨格系障害治療薬の世界市場（2022年）
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 300 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界の筋骨格系障害治療薬市場について調査分析し、市場の特徴、市場の動向と戦略、市場分析、競合情勢など、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 レポートの構造

第3章 筋骨格系障害治療薬市場の特徴

  • 市場の定義
  • 主要セグメンテーション

第4章 筋骨格系障害治療薬市場製品分析

  • 主要な製品/サービス
  • 主な機能と差別化要因
  • 開発製品

第5章 筋骨格系障害治療薬市場のサプライチェーン

  • サプライチェーン
  • 流通
  • エンドカスタマー

第6章 筋骨格系障害治療薬市場の顧客情報

  • 顧客の好み
  • 最終用途の市場規模と成長

第7章 筋骨格系障害治療薬市場の動向と戦略

第8章 筋骨格系障害治療薬に対するCOVID-19の影響

第9章 筋骨格系障害治療薬の市場規模と成長

  • 市場規模
  • 市場成長実績、金額（10億米ドル）
    • 市場促進要因
    • 市場抑制要因
  • 市場成長予測、金額（10億米ドル）
    • 市場促進要因
    • 市場抑制要因

第10章 筋骨格系障害治療薬市場地域分析

  • 世界の筋骨格系障害治療薬市場、金額（10億米ドル）（2021年）：地域別
  • 世界の筋骨格系障害治療薬市場、実績および予測（2016年～2021年）（2021年～2026年）（2031年）：地域別
  • 世界の筋骨格系障害治療薬市場、成長および市場シェアの比較：地域別

第11章 筋骨格系障害治療薬市場のセグメンテーション

  • 世界の筋骨格系障害治療薬市場、実績および予測、10億米ドル（2016年～2021年）（2021年～2026年）（2031年）：タイプ別
  • 医薬品
  • 生物製剤
  • 世界の筋骨格系障害治療薬市場、実績および予測、10億米ドル（2016年～2021年）（2021年～2026年）（2031年）：薬剤タイプ別
  • 関節リウマチの薬
  • 筋弛緩薬
  • その他の筋骨格系障害治療薬
  • 世界の筋骨格系障害治療薬市場、実績および予測、10億米ドル（2016年～2021年）（2021年～2026年）（2031年）：流通チャネル別
  • 病院薬局
  • 小売薬局/ドラッグストア
  • その他
  • 世界の筋骨格系障害治療薬市場、実績および予測、10億米ドル（2016年～2021年）（2021年～2026年）（2031年）：投与経路別
  • 経口
  • 非経口
  • その他
  • 世界の筋骨格系障害治療薬市場、実績および予測、10億米ドル（2016年～2021年）（2021年～2026年）（2031年）：薬剤分類別
  • ブランド薬
  • ジェネリック薬
  • 世界の筋骨格系障害治療薬市場、実績および予測、10億米ドル（2016年～2021年）（2021年～2026年）（2031年）：購入方法別
  • 処方薬
  • 市販薬

第12章 筋骨格系障害治療薬市場の測定基準

  • 筋骨格系障害治療薬の市場規模、GDPの割合、世界（2016年～2026年）
  • 一人当たりの平均筋骨格系障害治療薬市場支出、世界（2016年～2026年）

第13章 アジア太平洋地域の筋骨格系障害治療薬市場

第14章 西欧の筋骨格系障害治療薬市場

第15章 東欧の筋骨格系障害治療薬市場

第16章 北米の筋骨格系障害治療薬市場

第17章 南米の筋骨格系障害治療薬市場

第18章 中東筋骨格系障害治療薬市場

第19章 アフリカの筋骨格系障害治療薬市場

第20章 筋骨格系障害治療薬市場の競合情勢

  • 競合市場概要
  • 市場シェア
  • 企業プロファイル
    • Sanofi S.A
    • Pfizer Inc
    • Bristol-Myers Squibb
    • Eli Lilly And Company
    • Mitsubishi Tanabe Pharma Corporation

第21章 筋骨格系障害治療薬市場における主要な合併と買収

第22章 市場の背景：医薬品市場

  • 医薬品市場の特徴
  • 医薬品市場の実績と予測、成長、金額（10億米ドル）、世界（2016年～2021年）（2021年～2026年）（2031年）：セグメント別
  • 世界の医薬品市場、金額（10億米ドル）：地域別（2021年）
  • 世界の医薬品市場、実績および予測（2016年～2021年）（2021年～2026年）（2031年）：地域別
  • 世界の医薬品市場、金額（10億米ドル）（2016年～2021年）（2021年～2026年）（2031年）：タイプ別

第23章 推奨事項

  • 世界の筋骨格系障害治療薬市場 - 成長国（2026年）
  • 世界の筋骨格系障害治療薬市場 - 成長セグメント（2026年）
  • 世界の筋骨格系障害治療薬市場 - 成長戦略（2026年）

第24章 付録

第25章 著作権と免責事項

目次
Product Code: r680

“Musculoskeletal Disorders Drugs Global Market Report 2022” from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global musculoskeletal disorders drugs market as it emerges from the Covid 19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the musculoskeletal disorders drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The Musculoskeletal Disorders Drugs market global report” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider musculoskeletal disorders drugs market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the Covid 19 virus and forecasting its recovery.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The musculoskeletal disorders drugs market section of the report gives context. It compares the musculoskeletal disorders drugs market with other segments of the pharmaceutical drugs market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, musculoskeletal disorders drugs indicators comparison.

Scope

Markets Covered:

  • 1) By Type: Pharmaceutical Drugs; Biologics
  • 2) By Drug Type: Drugs For Rheumatoid Arthritis; Muscle Relaxants; Other Musculoskeletal Disorders Drugs
  • 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Others
  • 4) By Route Of Administration: Oral; Parenteral; Others
  • 5) By Drug Classification: Branded Drugs; Generic Drugs
  • 6) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs
  • Companies Mentioned: Sanofi S.A.; Pfizer Inc.; Bristol-Myers Squibb; Eli Lilly And Company; Mitsubishi Tanabe Pharma Corporation
  • Metrics Covered: Number of Enterprises; Number of Employees
  • Countries: Argentina; Australia; Austria; Belgium; Brazil; Canada; Chile; China; Colombia; Czech Republic; Denmark; Egypt; Finland; France; Germany; Hong Kong; India; Indonesia; Ireland; Israel; Italy; Japan; Malaysia; Mexico; Netherlands; New Zealand; Nigeria; Norway; Peru; Philippines; Poland; Portugal; Romania; Russia; Saudi Arabia; Singapore; South Africa; South Korea; Spain; Sweden; Switzerland; Thailand; Turkey; UAE; UK; USA; Venezuela; Vietnam
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, musculoskeletal disorders drugs indicators comparison.
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Report Structure

3. Musculoskeletal Disorders Drugs Market Characteristics

  • 3.1. Market Definition
  • 3.2. Key Segmentations

4. Musculoskeletal Disorders Drugs Market Product Analysis

  • 4.1. Leading Products/ Services
  • 4.2. Key Features and Differentiators
  • 4.3. Development Products

5. Musculoskeletal Disorders Drugs Market Supply Chain

  • 5.1. Supply Chain
  • 5.2. Distribution
  • 5.3. End Customers

6. Musculoskeletal Disorders Drugs Market Customer Information

  • 6.1. Customer Preferences
  • 6.2. End Use Market Size and Growth

7. Musculoskeletal Disorders Drugs Market Trends And Strategies

8. Impact Of COVID-19 On Musculoskeletal Disorders Drugs

9. Musculoskeletal Disorders Drugs Market Size And Growth

  • 9.1. Market Size
  • 9.2. Historic Market Growth, Value ($ Billion)
    • 9.2.1. Drivers Of The Market
    • 9.2.2. Restraints On The Market
  • 9.3. Forecast Market Growth, Value ($ Billion)
    • 9.3.1. Drivers Of The Market
    • 9.3.2. Restraints On The Market

10. Musculoskeletal Disorders Drugs Market Regional Analysis

  • 10.1. Global Musculoskeletal Disorders Drugs Market, 2021, By Region, Value ($ Billion)
  • 10.2. Global Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region
  • 10.3. Global Musculoskeletal Disorders Drugs Market, Growth And Market Share Comparison, By Region

11. Musculoskeletal Disorders Drugs Market Segmentation

  • 11.1. Global Musculoskeletal Disorders Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Pharmaceutical Drugs
  • Biologics
  • 11.2. Global Musculoskeletal Disorders Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Drugs For Rheumatoid Arthritis
  • Muscle Relaxants
  • Other Musculoskeletal Disorders Drugs
  • 11.3. Global Musculoskeletal Disorders Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies/ Drug Stores
  • Others
  • 11.4. Global Musculoskeletal Disorders Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Oral
  • Parenteral
  • Others
  • 11.5. Global Musculoskeletal Disorders Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Branded Drugs
  • Generic Drugs
  • 11.6. Global Musculoskeletal Disorders Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Prescription-Based Drugs
  • Over-The-Counter Drugs

12. Musculoskeletal Disorders Drugs Market Metrics

  • 12.1. Musculoskeletal Disorders Drugs Market Size, Percentage Of GDP, 2016-2026, Global
  • 12.2. Per Capita Average Musculoskeletal Disorders Drugs Market Expenditure, 2016-2026, Global

13. Asia-Pacific Musculoskeletal Disorders Drugs Market

  • 13.1. Asia-Pacific Musculoskeletal Disorders Drugs Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 13.2. Asia-Pacific, Musculoskeletal Disorders Drugs Market, 2021, By Country, Value ($ Billion)
  • 13.3. Asia-Pacific, Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • 13.4. Asia-Pacific, Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • 13.5. Asia-Pacific, Musculoskeletal Disorders Drugs Market Metrics
    • 13.5.1. Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2016-2026, Asia-Pacific Countries
    • 13.5.2. Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2021, Asia-Pacific Countries
  • 13.6. Asia-Pacific Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • 13.7. Asia-Pacific Musculoskeletal Disorders Drugs Market: Country Analysis
    • 13.7.1. China Musculoskeletal Disorders Drugs Market
      • 13.7.1.1. China Musculoskeletal Disorders Drugs Market Overview
      • 13.7.1.2. China Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 13.7.1.3. China Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.2. Australia Musculoskeletal Disorders Drugs Market
      • 13.7.2.1. Australia Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 13.7.2.2. Australia Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.3. Hong Kong Musculoskeletal Disorders Drugs Market
      • 13.7.3.1. Hong Kong Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.4. India Musculoskeletal Disorders Drugs Market
      • 13.7.4.1. India Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 13.7.4.2. India Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.5. Indonesia Musculoskeletal Disorders Drugs Market
      • 13.7.5.1. Indonesia Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 13.7.5.2. Indonesia Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.6. Japan Musculoskeletal Disorders Drugs Market
      • 13.7.6.1. Japan Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 13.7.6.2. Japan Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.7. Malaysia Musculoskeletal Disorders Drugs Market
      • 13.7.7.1. Malaysia Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.8. New Zealand Musculoskeletal Disorders Drugs Market
      • 13.7.8.1. New Zealand Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.9. Philippines Musculoskeletal Disorders Drugs Market
      • 13.7.9.1. Philippines Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.10. Singapore Musculoskeletal Disorders Drugs Market
      • 13.7.10.1. Singapore Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.11. South Korea Musculoskeletal Disorders Drugs Market
      • 13.7.11.1. South Korea Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 13.7.11.2. South Korea Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.12. Thailand Musculoskeletal Disorders Drugs Market
      • 13.7.12.1. Thailand Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 13.7.13. Vietnam Musculoskeletal Disorders Drugs Market
      • 13.7.13.1. Vietnam Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

14. Western Europe Musculoskeletal Disorders Drugs Market

  • 14.1. Western Europe Musculoskeletal Disorders Drugs Market Overview
  • 14.2. Western Europe, Musculoskeletal Disorders Drugs Market, 2021, By Country, Value ($ Billion)
  • 14.3. Western Europe, Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • 14.4. Western Europe, Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • 14.5. Western Europe, Musculoskeletal Disorders Drugs Market Metrics
    • 14.5.1. Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2016-2026, Western Europe Countries
    • 14.5.2. Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2021, Western Europe Countries
  • 14.6. Western Europe Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • 14.7. Western Europe Musculoskeletal Disorders Drugs Market: Country Analysis
    • 14.7.1. Austria Musculoskeletal Disorders Drugs Market
      • 14.7.1.1. Austria Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.2. Belgium Musculoskeletal Disorders Drugs Market
      • 14.7.2.1. Belgium Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.3. Denmark Musculoskeletal Disorders Drugs Market
      • 14.7.3.1. Denmark Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.4. Finland Musculoskeletal Disorders Drugs Market
      • 14.7.4.1. Finland Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.5. France Musculoskeletal Disorders Drugs Market
      • 14.7.5.1. France Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 14.7.5.2. France Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.6. Germany Musculoskeletal Disorders Drugs Market
      • 14.7.6.1. Germany Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 14.7.6.2. Germany Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.7. Ireland Musculoskeletal Disorders Drugs Market
      • 14.7.7.1. Ireland Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.8. Italy Musculoskeletal Disorders Drugs Market
      • 14.7.8.1. Italy Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.9. Netherlands Musculoskeletal Disorders Drugs Market
      • 14.7.9.1. Netherlands Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.10. Norway Musculoskeletal Disorders Drugs Market
      • 14.7.10.1. Norway Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.11. Portugal Musculoskeletal Disorders Drugs Market
      • 14.7.11.1. Portugal Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.12. Spain Musculoskeletal Disorders Drugs Market
      • 14.7.12.1. Spain Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.13. Sweden Musculoskeletal Disorders Drugs Market
      • 14.7.13.1. Sweden Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.14. Switzerland Musculoskeletal Disorders Drugs Market
      • 14.7.14.1. Switzerland Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 14.7.15. UK Musculoskeletal Disorders Drugs Market
      • 14.7.15.1. UK Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 14.7.15.2. UK Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

15. Eastern Europe Musculoskeletal Disorders Drugs Market

  • 15.1. Eastern Europe Musculoskeletal Disorders Drugs Market Overview
  • 15.2. Eastern Europe, Musculoskeletal Disorders Drugs Market, 2021, By Country, Value ($ Billion)
  • 15.3. Eastern Europe, Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • 15.4. Eastern Europe, Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • 15.5. Eastern Europe, Musculoskeletal Disorders Drugs Market Metrics
    • 15.5.1. Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2016-2026, Eastern Europe Countries
    • 15.5.2. Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2021, Eastern Europe Countries
  • 15.6. Eastern Europe Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • 15.7. Eastern Europe Musculoskeletal Disorders Drugs Market: Country Analysis
    • 15.7.1. Czech Republic Musculoskeletal Disorders Drugs Market,
      • 15.7.1.1. Czech Republic Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 15.7.2. Poland Musculoskeletal Disorders Drugs Market
      • 15.7.2.1. Poland Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 15.7.3. Romania Musculoskeletal Disorders Drugs Market
      • 15.7.3.1. Romania Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 15.7.4. Russia Musculoskeletal Disorders Drugs Market
      • 15.7.4.1. Russia Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 15.7.4.2. Russia Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

16. North America Musculoskeletal Disorders Drugs Market

  • 16.1. North America Musculoskeletal Disorders Drugs Market Overview
  • 16.2. North America, Musculoskeletal Disorders Drugs Market, 2021, By Country, Value ($ Billion)
  • 16.3. North America, Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • 16.4. North America, Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • 16.5. North America, Musculoskeletal Disorders Drugs Market Metrics
    • 16.5.1. Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2016-2026, North America Countries
    • 16.5.2. Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2021, North America Countries
  • 16.6. North America Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • 16.7. North America Musculoskeletal Disorders Drugs Market: Country Analysis
    • 16.7.1. Canada Musculoskeletal Disorders Drugs Market
      • 16.7.1.1. Canada Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 16.7.2. Mexico Musculoskeletal Disorders Drugs Market
      • 16.7.2.1. Mexico Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 16.7.3. USA Musculoskeletal Disorders Drugs Market
      • 16.7.3.1. USA Musculoskeletal Disorders Drugs Market Overview
      • 16.7.3.2. USA Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 16.7.3.3. USA Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

17. South America Musculoskeletal Disorders Drugs Market

  • 17.1. South America Musculoskeletal Disorders Drugs Market Overview
  • 17.2. South America, Musculoskeletal Disorders Drugs Market, 2021, By Country, Value ($ Billion)
  • 17.3. South America, Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • 17.4. South America, Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • 17.5. South America, Musculoskeletal Disorders Drugs Market Metrics
    • 17.5.1. Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2016-2026, South America Countries
    • 17.5.2. Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2021, South America Countries
  • 17.6. South America Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • 17.7. South America Musculoskeletal Disorders Drugs Market: Country Analysis
    • 17.7.1. Argentina Musculoskeletal Disorders Drugs Market
      • 17.7.1.1. Argentina Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 17.7.2. Brazil Musculoskeletal Disorders Drugs Market
      • 17.7.1.1. Brazil Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
      • 17.7.2.2. Brazil Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 17.7.3. Chile Musculoskeletal Disorders Drugs Market
      • 17.7.3.1. Chile Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 17.7.4. Colombia Musculoskeletal Disorders Drugs Market
      • 17.7.4.1. Colombia Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 17.7.5. Peru Musculoskeletal Disorders Drugs Market
      • 17.7.5.1. Peru Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 17.7.6. Venezuela Musculoskeletal Disorders Drugs Market
      • 17.7.6.1. Venezuela Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

18. Middle East Musculoskeletal Disorders Drugs Market

  • 18.1. Middle East Musculoskeletal Disorders Drugs Market Overview
  • 18.2. Middle East, Musculoskeletal Disorders Drugs Market, 2021, By Country, Value ($ Billion)
  • 18.3. Middle East, Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • 18.4. Middle East, Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • 18.5. Middle East, Musculoskeletal Disorders Drugs Market Metrics
    • 18.5.1. Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2016-2026, Middle East Countries
    • 18.5.2. Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2021, Middle East Countries
  • 18.6. Middle East Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • 18.7. Middle East Musculoskeletal Disorders Drugs Market: Country Analysis
    • 18.7.1. Saudi Arabia Musculoskeletal Disorders Drugs Market
      • 18.7.1.1. Saudi Arabia Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 18.7.2. Israel Musculoskeletal Disorders Drugs Market
      • 18.7.2.1. Israel Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 18.7.3. Turkey Musculoskeletal Disorders Drugs Market
      • 18.7.3.1. Turkey Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 18.7.4. UAE Musculoskeletal Disorders Drugs Market
      • 18.7.4.1. UAE Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

19. Africa Musculoskeletal Disorders Drugs Market

  • 19.1. Africa Musculoskeletal Disorders Drugs Market Overview
  • 19.2. Africa, Musculoskeletal Disorders Drugs Market, 2021, By Country, Value ($ Billion)
  • 19.3. Africa, Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • 19.4. Africa, Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • 19.5. Africa, Musculoskeletal Disorders Drugs Market Metrics
    • 19.5.1. Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2016-2026, Africa Countries
    • 19.5.2. Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2021, Africa Countries
  • 19.6. Africa Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • 19.7. Africa Musculoskeletal Disorders Drugs Market: Country Analysis
    • 19.7.1. Egypt Musculoskeletal Disorders Drugs Market
      • 19.7.1.1. Egypt Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 19.7.2. Nigeria Musculoskeletal Disorders Drugs Market
      • 19.7.2.1. Nigeria Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
    • 19.7.3. South Africa Musculoskeletal Disorders Drugs Market
      • 19.7.3.1. South Africa Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

20. Musculoskeletal Disorders Drugs Market Competitive Landscape

  • 20.1. Competitive Market Overview
  • 20.2. Market Shares
  • 20.3. Company Profiles
    • 20.3.1. Sanofi S.A
      • 20.3.1.1. Company Overview
      • 20.3.1.2. Products And Services
      • 20.3.1.3. Strategy
      • 20.3.1.4. Financial Performance
    • 20.3.2. Pfizer Inc
      • 20.3.2.1. Company Overview
      • 20.3.2.2. Products And Services
      • 20.3.2.3. Strategy
      • 20.3.2.4. Financial Performance
    • 20.3.3. Bristol-Myers Squibb
      • 20.3.3.1. Company Overview
      • 20.3.3.2. Products And Services
      • 20.3.3.3. Strategy
      • 20.3.3.4. Financial Performance
    • 20.3.4. Eli Lilly And Company
      • 20.3.4.1. Company Overview
      • 20.3.4.2. Products And Services
      • 20.3.4.3. Strategy
      • 20.3.4.4. Financial Performance
    • 20.3.5. Mitsubishi Tanabe Pharma Corporation
      • 20.3.5.1. Company Overview
      • 20.3.5.2. Products And Services
      • 20.3.5.3. Strategy
      • 20.3.5.4. Financial Performance

21. Key Mergers And Acquisitions In The Musculoskeletal Disorders Drugs Market

22. Market Background: Pharmaceutical Drugs Market

  • 22.1. Pharmaceutical Drugs Market Characteristics
  • 22.2. Pharmaceutical Drugs Market Historic and Forecast, 2016-2021, 2021-2026F, 2031F Growth, By Segment, Value ($ Billion), Global
  • 22.3. Global Pharmaceutical Drugs Market, 2021, By Region, Value ($ Billion)
  • 22.4. Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region
  • 22.5. Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Segmentation By Type, Value ($ Billion)

23. Recommendations

  • 23.1. Global Musculoskeletal Disorders Drugs Market In 2026- Growth Countries
  • 23.2. Global Musculoskeletal Disorders Drugs Market In 2026- Growth Segments
  • 23.3. Global Musculoskeletal Disorders Drugs Market In 2026- Growth Strategies

24. Appendix

  • 24.1. NAICS Definitions Of Industry Covered In This Report
  • 24.2. Abbreviations
  • 24.3. Currencies
  • 24.4. Research Inquiries
  • 24.5. The Business Research Company

25. Copyright And Disclaimer